MedTrace Logo

Efficacy and Safety of TORS for SCCA

NCT01819480 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2024-02-09

No results posted yet for this study

Summary

The purpose of this study is to learn more about the outcomes of treatment of throat and voice box cancers using transoral robotic surgery (TORS). TORS is a relatively new option involving the use of the da Vinci surgical robot to remove these cancers through the mouth.

Conditions

  • Oropharyngeal Squamous Cell Carcinoma
  • Supraglottic Squamous Cell Carcinoma

Interventions

PROCEDURE

Transoral robotic surgery

Transoral robotic surgery using the daVinci robot to remove primary tumor

Sponsors & Collaborators

  • Katherine L Fedder

    lead OTHER

Principal Investigators

  • Katherine L Fedder, MD · University of Virginia School of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01819480 on ClinicalTrials.gov